CĂRȚI ÎN ENGLEZĂ ÎN LEGĂTURĂ CU «HERCEPTIN»
Descoperă întrebuințarea
Herceptin în următoarea selecție bibliografică. Cărți în legătură cu
Herceptin și extrase din aceasta pentru a furniza contextul de întrebuințare al acestuia în literatura Engleză.
1
Her-2: The Making of
Herceptin, a Revolutionary Treatment ...
Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science. From the Hardcover edition.
2
HER2: Basic Research, Prognosis and Therapy
In contrast, the most potent variant, hu- MAb4D5-8 (now Herceptin), binds to
HER2 250-fold and 3-fold more tightly than hu- MAb4D5-l and 4D5, respectively.
In addition, Herceptin approaches the potency of the murine parent antibody in ...
3
Principles of Cancer Biotherapy
In September 1998 the U.S. FDA approved trastuzumab (Herceptin), a
humanized Mab that reacts with the second component of human epidermal
growth factor receptor (EGFR), known as Her2, for the treatment of metastatic
breast cancer, ...
Robert K. Oldham, Robert O. Dillman,
2009
4
Clinical Radiation Oncology
The first EGFR family targeted agent to be approved for clinical use was the
HER2-specific antibody, trastuzumab (Herceptin, Genentech, Inc., South San
Francisco, CA). Herceptin binds to the extracellular domain of HER2, enhancing
receptor ...
Leonard L. Gunderson, Joel E. Tepper, M.d.,
2007
Herceptin® land its murine equivalentl actually acts as a weak agonist lrather
than inhibitorl of ErbB2 under certain conditions. enhancing its au-
tophosphorylation [75]. It therefore appears that the interaction of Herceptin® with
domain IV of ...
6
Biotechnology: Academic Cell Update Edition
The first humanized monoclonal antibody approved for clinical use, trastuzumab (
Herceptin), is for the treatment of breast cancer. The Federal Drug Administration
(FDA) approved this therapeutic agent in 1998. Herceptin recognizes a cell ...
David P. Clark, Nanette J. Pazdernik,
2011
7
Advances in Breast Cancer Management, 2nd edition
The preclinical studies would predict that Herceptin efficacy is likely to be
restricted to cancers that exhibit amplified/overexpression of HER- 2/neu. The
initial clinical data seem to support this, however, the question is yet to be
completely ...
William J. Gradishar, William C. Wood,
2000
8
Design and Analysis of Clinical Trials: Concepts and ...
In other words, one out of five samples tested by these two devices with a
threshold of 2+ would yield different results. In other words, the result of one in
five by one assay indicates that the patient should be given Herceptin or lapatinib
. But the ...
Shein-Chung Chow, Jen-Pei Liu,
2013
Tumor growth inhibition in vivo was typically observed with tumor xenografts
models at Herceptin doses that ranged from 1 to 10mgkg−1, with inter- study
variations due to tumor type, level of p185HER2 expression, tumor vascularity,
tumor ...
Yuti Chernajovsky, Ahuva Nissim,
2007
10
Magnetic Nanomaterials
were, to a large extent, due to endocytosis via a receptor-mediated mechanism,
where the immobilized herceptin on the nanospheres targets the HER-2
receptors on the cells. In order to investigate the competitive effects of free
herceptin on ...
Challa S. S. R. Kumar,
2009
ȘTIRI NOI CARE INCLUD TERMENUL «HERCEPTIN»
Află ce ziare naționale și internaționale au scris despre și cum este întrebuințat termenul
Herceptin în contextul următoarelor știri.
Stocks Trend Analysis – Oncothyreon Inc (USA) (ONTY), Banco …
... HER2 inhibitor, which is in two Phase 1b trials, one in combination with Kadcyla and another in combination with Xeloda and/or Herceptin. «Investor Wired, Iul 15»
United States Breast Cancer Therapy Market Opportunity Analysis
Herceptin (Trastuzumab monoclonal antibody) is commonly prescribed breast cancer medicine. Roche developed Pertuzumab monoclonal ... «Satellite PR News, Iul 15»
Drug Combo Effective for Metastatic HER2+ Breast Ca | Medpage …
The combination of lapatinib (Tykerb) and trastuzumab (Herceptin) is active and well-tolerated when given to patients with human epidermal ... «MedPage Today, Iul 15»
Best Shares to Buy in 2015: Repligen
Some of the biggest drugs that require Protein A are the colon-cancer drug Avastin, the breast-cancer drug Herceptin, and the rheumatoid ... «Money Morning, Iul 15»
What Is Chemotherapy? The Ins And Outs Of Treatment, And How It …
... may need, for example, a year of Herceptin-based chemotherapy followed by five years of tamoxifen for [hormone-driven] breast cancer.” ... «Medical Daily, Iul 15»
Novasep bets on global antibody drug conjugate market with an …
The drug makes use of the Herceptin antibody to deliver a chemotherapeutic drug that's being investigated in other ADCs as well. In clinical ... «Companiesandmarkets.com, Iul 15»
Closure of chemotherapy unit at William Harvey Hospital means …
From her fourth session she will also be given the drug Herceptin, which will reduce the chances of her cancer returning but can have an effect ... «Kent Online, Iul 15»
Imugene Improved HER-Vaxx
HER-Vaxx could replicate or improve on the combination of two proven therapeutic antibodies, Herceptin and Perjeta (Roche), which ... «Investing.com, Iul 15»
Research and Markets: United States Breast Cancer Therapy Market …
Herceptin (Trastuzumab monoclonal antibody) is commonly prescribed breast cancer medicine. Roche developed Pertuzumab monoclonal ... «Business Wire, Iul 15»
Getting into the team spirit
“I'm alive today because of the grace of God and the drug Herceptin,” Jackson said. “The research grant for the drug was funded by the ACS. «Mendota Reporter, Iul 15»